Browsing: Gender-Affirming Care

A new research paper reveals severe adverse effects including declining mental health, increased depression, self-harm, and suicide ideation among trans and non-binary young people and their parents following the UK puberty blocker ban Continue Reading The UK Puberty Blocker Ban: Evidence Reveals Widespread Harm to Transgender Children

Sullivan Report Editorial Criticism: The Observer faces criticism for its editorial on the Sullivan Report which promoted gender-critical views, leading a reader to cancel their subscription, while TransLucent is also critical. Continue Reading Open Letter to The Observer re Sullivan Report

The Cass Report is controversial because many organisations have criticised it, contrasting it with the more transparent Swiss Report which contradicts Cass in its approach to treatment, evidence, and data interpretation. Continue Reading The Cass Report Scandal

Gender Exploratory Therapy (GET) – Conversion Therapy explores the reasoning behind a patient’s gender dysphoria, but there are concerns that it is a conversion therapy technique that can inflict harm on trans youth by tying dysphoria to trauma, delaying access to gender-affirming care and lacking an estimated duration for the therapy.
Continue Reading Gender Exploratory Therapy (GET) – Conversion Therapy

Misinformation about transgender healthcare, often originating from US-based organisations, is being spread globally, targeting gender-affirming healthcare, and puberty blockers. This misinformation relies on false claims about the risks of puberty blockers, the alleged widespread regret of transitioning individuals (contradicted by a 95%-98% satisfaction rate), and the unfounded concept of Rapid Onset Gender Dysphoria (ROGD) purported to be a social contagion. Continue Reading Transgender Health – Misinformation